Skip to main content

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Reply to the letter to the editor 'Re-aligning the ASCO and ESMO clinical benefit frameworks or modern cancer therapies'.

PMID: 29161364
Journal: ANNALS OF ONCOLOGY
Year: 2018
Reference: Ann Oncol. 2018 Mar 1;29(3):774-775. doi: 10.1093/annonc/mdx747.
Impact factor: 13.926
Publication type: Letter or abstract
Authors: Cherny, N I, Dafni, U, Latino, N J, Pentheroudakis, G, Douillard, J-Y, Tabernero, J, Zielinski, C, Piccart, M J, de Vries, E G E, Bogaerts, J et al.
DOI: 10.1093/annonc/mdx747

Reply to the letter to the editor 'Re-aligning the ASCO and ESMO clinical benefit frameworks or modern cancer therapies'.

PMID: 29161364
Journal: ANNALS OF ONCOLOGY
Year: 2018
Reference: Ann Oncol. 2018 Mar 1;29(3):774-775. doi: 10.1093/annonc/mdx747.
Impact factor:
Publication type: Letter or abstract
Authors: Bogaerts, J; Cherny, N I; Dafni, U; de Vries, E G E; Douillard, J-Y; Latino, N J; Pentheroudakis, G; Piccart, M J; Tabernero, J; Zielinski, C et al.
DOI: 10.1093/annonc/mdx747

Reply to the letter to the editor 'Toxicity adjustment in the ESMO-MCBS: a Gestalt approach?' by Del Paggio.

PMID: 29045537
Journal: ANNALS OF ONCOLOGY
Year: 2018
Reference: Ann Oncol. 2018 Feb 1;29(2):521-522. doi: 10.1093/annonc/mdx649.
Impact factor: 13.926
Publication type: Letter or abstract
Authors: Cherny, N I, Dafni, U, Bogaerts, J, Latino, N J, Pentheroudakis, G, Douillard, J-Y, Zielinski, C, Piccart, M J, de Vries, E G E, Tabernero, J et al.
DOI: 10.1093/annonc/mdx649

Reply to the letter to the editor 'Toxicity adjustment in the ESMO-MCBS: a Gestalt approach?' by Del Paggio.

PMID: 29045537
Journal: ANNALS OF ONCOLOGY
Year: 2018
Reference: Ann Oncol. 2018 Feb 1;29(2):521-522. doi: 10.1093/annonc/mdx649.
Impact factor:
Publication type: Letter or abstract
Authors: Bogaerts, J; Cherny, N I; Dafni, U; de Vries, E G E; Douillard, J-Y; Latino, N J; Pentheroudakis, G; Piccart, M J; Tabernero, J; Zielinski, C et al.
DOI: 10.1093/annonc/mdx649

Report on the status of women occupying leadership roles in oncology.

PMID: 30273418
Journal: ESMO open
Year: 2018
Reference: ESMO Open. 2018 Sep 21;3(6):e000423. doi: 10.1136/esmoopen-2018-000423. eCollection 2018.
Impact factor: 0
Publication type: Paper in international publication
Authors: Hofstadter-Thalmann, Eva, Dafni, Urania, Allen, Tamara, Arnold, Dirk, Banerjee, Susana, Curigliano, Giuseppe M.D, Garralda, Elena, Garassino, Marina Chiara, Haanen, John, Robert, Caroline et al.
DOI: 10.1136/esmoopen-2018-000423

Report on the status of women occupying leadership roles in oncology.

PMID: 30273418
Journal: ESMO open
Year: 2018
Reference: ESMO Open. 2018 Sep 21;3(6):e000423. doi: 10.1136/esmoopen-2018-000423. eCollection 2018.
Impact factor:
Publication type: Paper in international publication
Authors: Allen, Tamara; Arnold, Dirk; Banerjee, Susana; Curigliano, Giuseppe M.D; Dafni, Urania; Garassino, Marina Chiara; Garralda, Elena; Haanen, John; Hofstadter-Thalmann, Eva; Peters, Solange et al.
DOI: 10.1136/esmoopen-2018-000423

Reporting suspected adverse reactions to new commercialized medicines in real world.

PMID: 29359623
Journal: Multiple Sclerosis Journal
Year: 2018
Reference: Mult Scler. 2018 May;24(6):816-817. doi: 10.1177/1352458518754999. Epub 2018 Jan 23.
Impact factor: 5.28
Publication type: Paper in international publication
Authors: Agusti Escasany, Antonia et al.
DOI: 10.1177/1352458518754999

Reporting suspected adverse reactions to new commercialized medicines in real world.

PMID: 29359623
Journal: Multiple Sclerosis Journal
Year: 2018
Reference: Mult Scler. 2018 May;24(6):816-817. doi: 10.1177/1352458518754999. Epub 2018 Jan 23.
Impact factor:
Publication type: Paper in international publication
Authors: Agusti Escasany, Antonia et al.
DOI: 10.1177/1352458518754999

Resistance of high fitness hepatitis C virus to lethal mutagenesis.

PMID: 30107298
Journal: VIROLOGY
Year: 2018
Reference: Virology. 2018 Oct;523:100-109. doi: 10.1016/j.virol.2018.07.030. Epub 2018 Aug 11.
Impact factor: 3.374
Publication type: Paper in international publication
Authors: Gallego, Isabel, Gregori, Josep, Soria, Maria Eugenia, Garcia-Crespo, Carlos, Garcia-Alvarez, Monica, Gomez-Gonzalez, Alfonso, Valiergue, Rosalie, Gomez, Jordi, Esteban, Juan Ignacio, Quer, Josep et al.
DOI: 10.1016/j.virol.2018.07.030

Resistance of high fitness hepatitis C virus to lethal mutagenesis.

PMID: 30107298
Journal: VIROLOGY
Year: 2018
Reference: Virology. 2018 Oct;523:100-109. doi: 10.1016/j.virol.2018.07.030. Epub 2018 Aug 11.
Impact factor:
Publication type: Paper in international publication
Authors: Domingo, Esteban; Esteban, Juan Ignacio; Gallego, Isabel; Garcia-Alvarez, Monica; Garcia-Crespo, Carlos; Gomez, Jordi; Gomez-Gonzalez, Alfonso; Gregori, Josep; Perales, Celia; Quer, Josep et al.
DOI: 10.1016/j.virol.2018.07.030

Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.

PMID: 29785104
Journal: International Journal of Chronic Obstructive Pulmonary Disease
Year: 2018
Reference: Int J Chron Obstruct Pulmon Dis. 2018 May 11;13:1545-1556. doi: 10.2147/COPD.S154097. eCollection 2018.
Impact factor: 2.917
Publication type: Paper in international publication
Authors: Wehrmeister, Fernando C, Casas, Alejandro, Montes de Oca, Maria, Menezes, Ana Mb, Ramirez, Larissa, Miravitlles, Marc, Mendoza, Laura, Lopez Varela, Maria Victorina et al.
DOI: 10.2147/COPD.S154097

Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.

PMID: 29785104
Journal: International Journal of Chronic Obstructive Pulmonary Disease
Year: 2018
Reference: Int J Chron Obstruct Pulmon Dis. 2018 May 11;13:1545-1556. doi: 10.2147/COPD.S154097. eCollection 2018.
Impact factor:
Publication type: Paper in international publication
Authors: Casas, Alejandro; Lopez Varela, Maria Victorina; Mendoza, Laura; Menezes, Ana Mb; Miravitlles, Marc; Montes de Oca, Maria; Ramirez, Larissa; Wehrmeister, Fernando C et al.
DOI: 10.2147/COPD.S154097

Respiratory support therapy after extubation: Who and how?

PMID: 29122291
Journal: Medicina Intensiva
Year: 2018
Reference: Med Intensiva. 2018 May;42(4):255-257. doi: 10.1016/j.medin.2017.09.005. Epub 2017 Nov 6.
Impact factor: 1.755
Publication type: Review in international publication
Authors: Hernandez, G, Roca, O et al.
DOI: 10.1016/j.medin.2017.09.005

Respiratory support therapy after extubation: Who and how?

PMID: 29122291
Journal: Medicina Intensiva
Year: 2018
Reference: Med Intensiva. 2018 May;42(4):255-257. doi: 10.1016/j.medin.2017.09.005. Epub 2017 Nov 6.
Impact factor:
Publication type: Review in international publication
Authors: Hernandez, G; Roca, O et al.
DOI: 10.1016/j.medin.2017.09.005

RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.

PMID: 29371383
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2018
Reference: Eur Respir J. 2018 Jan 25;51(1). pii: 51/1/1702052. doi: 10.1183/13993003.02052-2017. Print 2018 Jan.
Impact factor: 12.242
Publication type: Paper in international publication
Authors: Wilson, Robert, Winthrop, Kevin L, Polverino, Eva, De Soyza, Anthony, Aksamit, Timothy, Bandel, Tiemo-Joerg, Criollo, Margarita, Elborn, J Stuart, Operschall, Elisabeth, Roth, Katrin et al.
DOI: 10.1183/13993003.02052-2017

RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.

PMID: 29371383
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2018
Reference: Eur Respir J. 2018 Jan 25;51(1). pii: 51/1/1702052. doi: 10.1183/13993003.02052-2017. Print 2018 Jan.
Impact factor:
Publication type: Paper in international publication
Authors: Aksamit, Timothy; Bandel, Tiemo-Joerg; Criollo, Margarita; De Soyza, Anthony; Elborn, J Stuart; Operschall, Elisabeth; Polverino, Eva; Roth, Katrin; Wilson, Robert; Winthrop, Kevin L et al.
DOI: 10.1183/13993003.02052-2017

RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.

PMID: 29371384
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2018
Reference: Eur Respir J. 2018 Jan 25;51(1). pii: 51/1/1702053. doi: 10.1183/13993003.02053-2017. Print 2018 Jan.
Impact factor: 12.242
Publication type: Paper in international publication
Authors: Aksamit, Timothy, De Soyza, Anthony, Bandel, Tiemo-Joerg, Criollo, Margarita, Elborn, J Stuart, Operschall, Elisabeth, Polverino, Eva, Roth, Katrin, Winthrop, Kevin L, Wilson, Robert et al.
DOI: 10.1183/13993003.02053-2017

RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.

PMID: 29371384
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2018
Reference: Eur Respir J. 2018 Jan 25;51(1). pii: 51/1/1702053. doi: 10.1183/13993003.02053-2017. Print 2018 Jan.
Impact factor:
Publication type: Paper in international publication
Authors: Aksamit, Timothy; Bandel, Tiemo-Joerg; Criollo, Margarita; De Soyza, Anthony; Elborn, J Stuart; Operschall, Elisabeth; Polverino, Eva; Roth, Katrin; Wilson, Robert; Winthrop, Kevin L et al.
DOI: 10.1183/13993003.02053-2017

Response to ECG, March 2018.

PMID: 29587995
Journal: REVISTA ESPANOLA DE CARDIOLOGIA
Year: 2018
Reference: Rev Esp Cardiol (Engl Ed). 2018 Apr;71(4):295. doi: 10.1016/j.rec.2017.09.019.
Impact factor: 5.166
Publication type: Letter or abstract
Authors: Figueras-Coll, Marc, Rivas-Gandara, Nuria, Roses-Noguer, Ferran et al.
DOI: 10.1016/j.rec.2017.09.019

Response to ECG, March 2018.

PMID: 29587995
Journal: REVISTA ESPANOLA DE CARDIOLOGIA
Year: 2018
Reference: Rev Esp Cardiol (Engl Ed). 2018 Apr;71(4):295. doi: 10.1016/j.rec.2017.09.019.
Impact factor:
Publication type: Letter or abstract
Authors: Figueras-Coll, Marc; Rivas-Gandara, Nuria; Roses-Noguer, Ferran et al.
DOI: 10.1016/j.rec.2017.09.019

Response to Letter to the Editor.

PMID: 30086556
Journal: NEUROPEDIATRICS
Year: 2018
Reference: Neuropediatrics. 2018 Oct;49(5):355. doi: 10.1055/s-0038-1667354. Epub 2018 Aug 7.
Impact factor: 1.605
Publication type: Letter or abstract
Authors: Macaya, Alfons, Boronat, Susana et al.
DOI: 10.1055/s-0038-1667354

Response to Letter to the Editor.

PMID: 30086556
Journal: NEUROPEDIATRICS
Year: 2018
Reference: Neuropediatrics. 2018 Oct;49(5):355. doi: 10.1055/s-0038-1667354. Epub 2018 Aug 7.
Impact factor:
Publication type: Letter or abstract
Authors: Boronat, Susana; Macaya, Alfons et al.
DOI: 10.1055/s-0038-1667354

Response to oral sucrosomial iron supplementation in patients undergoing bariatric surgery. The BARI-FER study.

PMID: 29233512
Journal: Endocrinologia, diabetes y nutricion
Year: 2018
Reference: Endocrinol Diabetes Nutr. 2018 Jan;65(1):17-20. doi: 10.1016/j.endinu.2017.10.007. Epub 2017 Dec 7.
Impact factor: 0
Publication type: Paper in national publication
Authors: Simo, Rafael, Mesa, Jordi, Hernandez, Cristina, Vilallonga, Ramon, Balibrea, Jose Maria, Simo-Servat, Olga, Ciudin, Andreea et al.
DOI: 10.1016/j.endinu.2017.10.007

Response to oral sucrosomial iron supplementation in patients undergoing bariatric surgery. The BARI-FER study.

PMID: 29233512
Journal: Endocrinologia, diabetes y nutricion
Year: 2018
Reference: Endocrinol Diabetes Nutr. 2018 Jan;65(1):17-20. doi: 10.1016/j.endinu.2017.10.007. Epub 2017 Dec 7.
Impact factor:
Publication type: Paper in national publication
Authors: Balibrea, Jose Maria; Ciudin, Andreea; Hernandez, Cristina; Mesa, Jordi; Simo, Rafael; Simo-Servat, Olga; Vilallonga, Ramon et al.
DOI: 10.1016/j.endinu.2017.10.007